Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 16, 2018

View Archived Issues

FDA expands approval of Gilotrif in NSCLC

SAAP-148 shows promise for combating multidrug-resistant bacteria

Prolong Pharmaceuticals gives update on ongoing projects

FDA approves of Trisenox injection for first-line treatment of acute promyelocytic leukemia

Eurocine Vaccines cleared to begin study of Immunose Flu

InflaRx presents company and pipeline overview

Nanoparticle-encapsulated rapamycin induces immune tolerance to restore immunotoxin activity

FDA grants orphan drug designation to BB-301 for oculopharyngeal muscular dystrophy

FDA accepts Sandoz's BLA for adalimumab biosimilar

LIDDS raises capital through direct share issue

Suzhou Kintor Pharmaceuticals patents mTOR and/or PI3K inhibitors

Japanese approval sought for Opdivo with Yervoy for unresectable or metastatic renal cell carcinoma

Aprinoia Therapeutics completes series B financing round

ValiRx reports phase II data on VAL-401 in late-stage NSCLC

Universite Jagellonne and Neurolixis divulge 5-HT1A receptor agonists

Janssen identifies novel TLR7 and/or TLR8 agonists

Y-mAbs commences phase III study of naxitamab in neuroblastoma with osteomedullary disease

LifeArc presents novel antivirals for HFMD

Novel HLA-G-targeting antibodies presented by Invectys

NHLBI initiates phase I study of HERV-E TCR transduced autologous T cells in renal cell carcinoma

MedImmune studies MEDI-5884 in stable coronary heart disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...